G

Genelux Corp
NASDAQ:GNLX

Watchlist Manager
Genelux Corp
NASDAQ:GNLX
Watchlist
Price: 4.37 USD 4.05% Market Closed
Market Cap: 166.3m USD

Wall Street
Price Targets

GNLX Price Targets Summary
Genelux Corp

Wall Street analysts forecast GNLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GNLX is 19.72 USD with a low forecast of 10.1 USD and a high forecast of 32.55 USD.

Lowest
Price Target
10.1 USD
131% Upside
Average
Price Target
19.72 USD
351% Upside
Highest
Price Target
32.55 USD
645% Upside
Genelux Corp Competitors:
Price Targets
ALNY
Alnylam Pharmaceuticals Inc
22% Upside
6855
Ascentage Pharma Group International
88% Upside
LTRN
Lantern Pharma Inc.
467% Upside
RXRX
Recursion Pharmaceuticals Inc
63% Upside
688177
Bio-Thera Solutions Ltd
55% Upside
6160
Beigene Ltd
36% Upside
IKT
Inhibikase Therapeutics Inc
244% Upside
BMEA
Biomea Fusion Inc
437% Upside

Revenue
Forecast

Revenue Estimate
Genelux Corp

The compound annual growth rate of Genelux Corp's revenue for the next 4 years is 884%.

N/A
Past Growth
884%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genelux Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
Genelux Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GNLX's stock price target?
Price Target
19.72 USD

According to Wall Street analysts, the average 1-year price target for GNLX is 19.72 USD with a low forecast of 10.1 USD and a high forecast of 32.55 USD.

What is Genelux Corp's Revenue forecast?
Projected CAGR
884%

The compound annual growth rate of Genelux Corp's revenue for the next 4 years is 884%.

Back to Top